BAXTER INTERNATIONAL INC — Form 8-K
Filed July 30, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 48/100
What the filing says
Baxter reported Q2 2026 sales of $2.96B (+5% organic), with adjusted diluted EPS of $0.56 (down 5% YoY due to higher-cost inventory and functional cost reclassification, partially offset by $0.11/share IEEPA tariff refund). The company raised full-year 2026 guidance: reported sales growth to 3–4% (from flat–1%), organic growth to 2–3% (from ~flat), and adjusted diluted EPS to $1.95–$2.15 (from $1.85–$2.05).
Why this rating
Solid organic growth (+5% Q2) and guidance raise are encouraging, but tariff refund is one-time benefit. Core momentum modest; adjusted EPS down YoY. Meaningful for company trajectory but not transformational relative to $16B market cap.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.